These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28927969)

  • 41. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.
    Baethge C; Baldessarini RJ; Freudenthal K; Streeruwitz A; Bauer M; Bschor T
    Bipolar Disord; 2005 Apr; 7(2):136-45. PubMed ID: 15762854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.
    Kagal UA; Torgal SS; Patil NM; Malleshappa A
    J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
    McIntyre RS
    J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey.
    Yazici MK; Anil Yağcioğlu AE; Ertuğrul A; Eni N; Karahan S; Karaağaoğlu E; Tokgözoğlu SL
    Eur Arch Psychiatry Clin Neurosci; 2011 Feb; 261(1):69-78. PubMed ID: 20517698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?
    Papolos DF; Faedda GL; Veit S; Goldberg R; Morrow B; Kucherlapati R; Shprintzen RJ
    Am J Psychiatry; 1996 Dec; 153(12):1541-7. PubMed ID: 8942449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bipolar disorder and metabolic syndrome: a systematic review.
    Czepielewski L; Daruy Filho L; Brietzke E; Grassi-Oliveira R
    Braz J Psychiatry; 2013 Mar; 35(1):88-93. PubMed ID: 23567607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder.
    Gomes FA; Almeida KM; Magalhães PV; Caetano SC; Kauer-Sant'Anna M; Lafer B; Kapczinski F
    Braz J Psychiatry; 2013; 35(2):126-30. PubMed ID: 23904016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients.
    Fabrazzo M; Monteleone P; Prisco V; Perris F; Catapano F; Tortorella A; Monteleone AM; Steardo L; Maj M
    Neuropsychobiology; 2015; 72(1):29-36. PubMed ID: 26337616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.
    Saloojee S; Burns JK; Motala AA
    Early Interv Psychiatry; 2018 Dec; 12(6):1137-1143. PubMed ID: 28402033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
    McEvoy JP; Meyer JM; Goff DC; Nasrallah HA; Davis SM; Sullivan L; Meltzer HY; Hsiao J; Scott Stroup T; Lieberman JA
    Schizophr Res; 2005 Dec; 80(1):19-32. PubMed ID: 16137860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study.
    Balanzá-Martínez V; Tabarés-Seisdedos R; Selva-Vera G; Martínez-Arán A; Torrent C; Salazar-Fraile J; Leal-Cercós C; Vieta E; Gómez-Beneyto M
    Psychother Psychosom; 2005; 74(2):113-9. PubMed ID: 15741761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
    Sugawara N; Yasui-Furukori N; Sato Y; Umeda T; Kishida I; Yamashita H; Saito M; Furukori H; Nakagami T; Hatakeyama M; Nakaji S; Kaneko S
    Schizophr Res; 2010 Nov; 123(2-3):244-50. PubMed ID: 20850274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minor physical anomalies in schizophrenia and bipolar I disorder and the neurodevelopmental continuum of psychosis.
    Akabaliev VH; Sivkov ST; Mantarkov MY
    Bipolar Disord; 2014 Sep; 16(6):633-41. PubMed ID: 24798215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
    Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
    J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.
    Cuturic M; Abramson RK; Breen RJ; Edwards AC; Levy EE
    World J Biol Psychiatry; 2016 Sep; 17(6):475-9. PubMed ID: 27088656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study.
    Salvi V; D'Ambrosio V; Bogetto F; Maina G
    J Affect Disord; 2012 Feb; 136(3):599-603. PubMed ID: 22119084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Crosscultural aspects of bipolar disorder: results of a comparative study between French and Tunisian patients].
    Douki S; Nacef F; Triki T; Dalery J
    Encephale; 2012 Jun; 38(3):194-200. PubMed ID: 22726407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.